Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Evgen Pharma presents 2022 clinical trials plans and progress with US and UK regulators

mel | 26 January 2022

Categories: Videos

Post navigation

← TheraCryf portfolio update on core field of cancer, ‘the R&D is entirely on plan and on budget’

Evgen Pharma talks through clinical milestones and financial results from its 2022 full-year report →

Privacy Policy
Data Protection Complaints Handling Process
Sitemap

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.